These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28888416)

  • 1. Toll Like Receptors in systemic sclerosis: An emerging target.
    O'Reilly S
    Immunol Lett; 2018 Mar; 195():2-8. PubMed ID: 28888416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity in systemic sclerosis pathogenesis.
    O'Reilly S
    Clin Sci (Lond); 2014 Mar; 126(5):329-37. PubMed ID: 24219159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of toll-like receptors in systemic sclerosis.
    Ciechomska M; Cant R; Finnigan J; van Laar JM; O'Reilly S
    Expert Rev Mol Med; 2013 Aug; 15():e9. PubMed ID: 23985302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of innate immune system in systemic sclerosis.
    Fullard N; O'Reilly S
    Semin Immunopathol; 2015 Sep; 37(5):511-7. PubMed ID: 26159672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis.
    Bhattacharyya S; Varga J
    Curr Rheumatol Rep; 2015 Jan; 17(1):474. PubMed ID: 25604573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate Immunity in Systemic Sclerosis.
    Dowson C; Simpson N; Duffy L; O'Reilly S
    Curr Rheumatol Rep; 2017 Jan; 19(1):2. PubMed ID: 28116578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
    Tartey S; Takeuchi O
    Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity and inflammation in systemic sclerosis.
    Lafyatis R; York M
    Curr Opin Rheumatol; 2009 Nov; 21(6):617-22. PubMed ID: 19633559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Toll-like receptors in periodontitis.
    Song B; Zhang YL; Chen LJ; Zhou T; Huang WK; Zhou X; Shao LQ
    Oral Dis; 2017 Mar; 23(2):168-180. PubMed ID: 26923115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern recognition by Toll-like receptors.
    Bauer S; Müller T; Hamm S
    Adv Exp Med Biol; 2009; 653():15-34. PubMed ID: 19799109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors: a family of innate sensors of danger that alert and drive immunity.
    Montero Vega MT; de Andrés Martín A
    Allergol Immunopathol (Madr); 2008; 36(6):347-57. PubMed ID: 19150035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases.
    Li M; Zhou Y; Feng G; Su SB
    Curr Mol Med; 2009 Apr; 9(3):365-74. PubMed ID: 19355917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors and their role in renal pathologies.
    Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I; Lawson BR
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):464-77. PubMed ID: 22931389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Toll-like receptors in autoimmunity.
    Midwood KS; Piccinini AM; Sacre S
    Curr Drug Targets; 2009 Nov; 10(11):1139-55. PubMed ID: 19715534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-Like Receptor Signaling and Its Inducible Proteins.
    Satoh T; Akira S
    Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28084212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
    Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
    Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic role of toll-like receptor modification in cardiovascular dysfunction.
    Navi A; Patel H; Shaw S; Baker D; Tsui J
    Vascul Pharmacol; 2013 Mar; 58(3):231-9. PubMed ID: 23070056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll like receptors and autoimmunity: a critical appraisal.
    Papadimitraki ED; Bertsias GK; Boumpas DT
    J Autoimmun; 2007 Dec; 29(4):310-8. PubMed ID: 17959357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
    Gabrielli A; Svegliati S; Moroncini G; Luchetti M; Tonnini C; Avvedimento EV
    Autoimmun Rev; 2007 Dec; 7(2):121-6. PubMed ID: 18035321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.